Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis
Lab / animal
OA: closed
CC0
⤵ 37 in-corpus citations
AI-generated summary
Recombinant interleukin-2 restored the diminished cytotoxic activity of T-cells against autologous endometrial cells in peripheral blood lymphocytes from endometriosis patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: It has been shown recently that women with endometriosis have several immunological defects. In particular, these patients have a defect in peripheral blood natural killer cell activity and have lost their capacity of recognizing and lysing autologous endometrial cells.
METHOD: We evaluated the effect of recombinant interleukin-2 (rIL-2) on peripheral blood lymphocytes obtained from both healthy donors and endometriosis patients. The generation of a strong cytolytic activity against autologous endometrial cells was obtained from both normal donors and endometriosis patients.
RESULTS: Interestingly, these cytolytic cells belong to the T-cell lineage and do not recognize both autologous keratinocytes and allogeneic endometrial cells, thus suggesting a mechanism of specific recognition of autologous cells.
CONCLUSION: The capability of restoring cytolytic activity using rIL-2 suggests a new immunotherapeutic approach for the treatment of severe endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (30)
- Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis via openalex
- Autoimmunity to endometrium and ovary in endometriosis via openalex
- Autoimmunity to Endometrium and Ovary in Endometriosis via openalex
- Deficient cellular immunity in endometriosis via openalex
- Immunologic aspects of human endometriosis via openalex
- Incidence of endometriosis in diagnostic laparoscopy via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis via openalex
- W2054716970 via openalex
- W2062964622 via openalex
- W2076973116 via openalex
- W2084895049 via openalex
- W2107359414 via openalex
- W2124314287 via openalex
- W2257161016 via openalex
- W2407038112 via openalex
- W2409202770 via openalex
- W2412915851 via openalex
- W2415098810 via openalex
- W2415338099 via openalex
- W2477008945 via openalex
- W1792786690 via openalex
- W6653086372 via openalex
- W141728048 via openalex
- W170259557 via openalex
- W1965302438 via openalex
- W2010852600 via openalex
- W2037581737 via openalex
- W2046103219 via openalex
- W2049043712 via openalex
Cited by (38)
- Immunologic Aspects of Endometriosis 2024
- Endometriosis as an autoimmune disease 2024
- Understanding endometriosis from an immunomicroenvironmental perspective 2023
- Reduced frequency of perforin-positive CD8+ T cells in menstrual effluent of endometriosis patients 2021
- Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target 2021
- The pathogenesis of endometriosis: clues from the immunological evidence 2021
- Reduced frequency of perforin-positive CD8+ T cells in menstrual effluent of endometriosis patients compared to healthy controls 2020
- NK Cells as Potential Targets for Immunotherapy in Endometriosis 2019
- The endometrial immune environment of women with endometriosis 2019
- Involvement of immune cells in the pathogenesis of endometriosis 2018
- Immunological aspects of endometriosis: a review 2015
- Roles of regulatory T cells in endometriosis-associated infertility 2014
- Recent advances in gene therapy of endometriosis 2014
- Lymphocytes in endometriosis 2010
- Treatment of endometriosis with transvaginal ultrasound-guided drainage and recombinant interleukin-2 left in the cysts: a third clinical trial 2009
- The effect of intraperitoneal interleukin-2 on surgically induced endometriosis in rats 2007
- Emerging drugs in endometriosis 2006
- The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women 2006
- Interleukin-2 receptor beta (IL-2R beta)-627*C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis 2005
- Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2 2005
- Treatment of endometriosis with transvaginal ultrasound-guided drainage under GnRH analogues and recombinant interleukin-2 left in the cysts 2005
- Endometriosis: epidemiology and aetiological factors 2004
- Endometriosis: epidemiology and aetiological factors 2004
- GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis 2003
- A defective expression of ICAM-1 (CD54) on secretory endometrial cells is associated with endometriosis 2002
- Use of intraperitoneal interferon alpha-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial 2002
- Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis 2000
- Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function? 1999
- The peritoneal fluid levels of interleukin-12 in women with endometriosis 1998
- Immunology and endometriosis. Fact, artifact, or epiphenomenon? 1997
- Peritoneal cellular immunity and endometriosis 1997
- Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis 1996
- Effect of endometriosis on white blood cell subpopulations in peripheral blood and peritoneal fluid of baboons 1996
- Immunological aspects of endometriosis 1996
- Killer cell activity, statistics, and endometriosis 1995
- IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis 1995
- IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis 1995
- The biological basis of medical treatment of endometriosis 1995
Source provenance
- europepmc
- last seen: 2026-10-17T06:09:56.316927+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:59:07.256998+00:00
- unpaywall
- last seen: 2026-10-17T06:24:38.187582+00:00
License: CC0
· commercial use OK